Why it Matters
The quantum computing company is betting big on federal policy influence investing $2.59 million in lobbying since 2021 across five firms. This latest hire brings specialized defense and appropriations expertise at a critical moment for quantum legislation.
By the Numbers
- $2.59 million spent since 2021
- 5 active lobbying firms
- Clark Street Associates LLC: $1.71 million (largest relationship)
- Holland & Knight LLP: $730,000
- K&L Gates LLP: $770,000
- Cole Rojewski leads the Bernhardt Group engagement with nearly 10 years of congressional experience
Broader Context
The National Quantum Initiative Act expired in September 2023, creating funding uncertainty. The 119th Congress has introduced unprecedented quantum legislation, including the Defense Quantum Acceleration Act with $20 million in annual authorizations. US-China quantum competition has intensified, making domestic quantum capabilities a national security priority.
The Agenda
IonQ is focusing on Budget/Appropriations and Defense issues. The company targets National Defense Authorization Acts, quantum reauthorization bills, and Commerce-Justice-Science appropriations. No specific legislation was disclosed in the new registration.
Competitive Landscape
Information about other quantum companies’ lobbying activities was not available in the provided materials.
Between The Lines
Multiple quantum bills are moving through Congress simultaneously. The Defense Department recently accelerated quantum initiatives, with IonQ deploying systems at Air Force Research Laboratory. The Advancing Quantum Manufacturing Act specifically mentions trapped ions – IonQ’s core technology. Defense appropriations bills have allocated “hundreds of millions” for quantum computing.
The Bottom Line
IonQ is positioning itself for a potential quantum funding bonanza. With Congress considering billions in quantum investments and new DoD quantum leadership structures, the company needs enhanced lobbying firepower to compete effectively.
Spot something wrong? Report an issue with this article